SEC Form 4 · accession 0001209191-15-084276
Sorrento Therapeutics, Inc. · SRNE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Patrick Soon-Shiong
10% Owner
MP 13 Ventures, LLC
10% Owner
Cambridge Equities, LP
10% Owner
Period of report
Dec 7, 2015
Accepted (ET)
Dec 9, 2015 · 4:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000850261
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 7, 2015 | A | 100,000 | $7.8909 | A | 820,174 | D | |
| Common StockF1 | Dec 8, 2015 | A | 14,000 | $8.011 | A | 834,174 | D | |
| Common StockF2 | holding | — | — | — | 7,188,061 | I | Through Cambridge Equities, LP |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WarrantF2,F3 | $5.80 | holding | — | — | — | Dec 22, 2014 | Dec 22, 2017 | Common Stock | 1,724,138 | 1,724,138 | I |
Explanation of responses
- F1These shares of common stock were acquired on the open market. The price reported in Column 4 is a weighted average sale price. Dr. Patrick Soon-Shiong undertakes to provide to Sorrento Therapeutics, Inc. (the "Company"), any securityholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the price at which these shares were acquired.
- F2Dr. Patrick Soon-Shiong is the sole member of MP 13 Ventures, LLC ("MP 13 Ventures"), which is the general partner of Cambridge Equities, LP ("Cambridge Equities").
- F3The exercise price of the Warrant is subject to customary adjustment provisions for stock splits, stock dividends, recapitalizations and the like.